Hello,

I am studying autophagic activity by using LC3B marker. I already know that my patient cell lines have higher levels of LC3BI and II forms compared to the control. However, these data by themselves are not really explicatory, so i would like to try and measure autophagic flux. In particular, firstly, I would like to determine if there is a difference in terms of flux in control vs patient cell lines, and then see if a treatment with a drug has an effect on the flux.

From the literature, I gathered that the lipidated form LC3B-II is the one I should be focusing on, as it is the form that better reflects the degradation of substrates through lysosomes. I have read that the best technique to measure this flux is by treating cells with a lysosomal inhibitor and then comparing the change in the LC3BI-II accumulation.

What is not really clear to me is what is the best way to "compare" these LC3B-II levels, as I have seen different things reported. Is it better to calculate and compare the difference in LC3B-II [AF = (sample + Baf) – (sample – Baf)] or the ratio [AF=(sample + BafA1)/ (sample – BafA1)]?

Any suggestion is very welcome, and thank you in advance!

More Giulia Pedrotti's questions See All
Similar questions and discussions